Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

3.4%

1 terminated out of 29 trials

Success Rate

94.7%

+8.2% vs benchmark

Late-Stage Pipeline

21%

6 trials in Phase 3/4

Results Transparency

44%

8 of 18 completed with results

Key Signals

8 with results95% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (2)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed18
Recruiting4
Withdrawn3
Unknown2
Not Yet Recruiting1
Terminated1

Trial Success Rate

94.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07172451Phase 4Recruiting

Gelaspan vs Crystalloid Therapy in Sepsis

NCT03482245Not ApplicableRecruiting

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

NCT06901544CompletedPrimary

Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients

NCT03544203CompletedPrimary

Multicentre Observational Study on Community Acquired Intraabdominal Infections Management

NCT07207291Phase 1Recruiting

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

NCT04612413Phase 2Completed

A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

NCT06838585CompletedPrimary

Intra-Abdominal Sepsis and Relationship Between Cumulative Fluid Balance and Serum Sodium and Chloride Levels and In-Hospital Mortality

NCT06828874Phase 4CompletedPrimary

A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria

NCT04094818Completed

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

NCT06633718Phase 3Not Yet RecruitingPrimary

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI

NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT02831556Completed

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

NCT05639504Withdrawn

Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)

NCT01431326Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

NCT05628493Completed

Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction

NCT04700787Phase 1Withdrawn

Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

NCT03744741Completed

HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study

NCT04240288Not ApplicableWithdrawnPrimary

Procalcitonin Guided Antibiotic Therapy

NCT03354754Phase 2TerminatedPrimary

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

NCT03862378Unknown

Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis

Scroll to load more

Research Network

Activity Timeline